-
1
-
-
0019422226
-
Can dietary beta-carotene materially reduce human cancer rates?
-
Peto R, Doll R, Buckley JD, et al. Can dietary beta-carotene materially reduce human cancer rates? Nature 1981; 290: 201-8.
-
(1981)
Nature
, vol.290
, pp. 201-208
-
-
Peto, R.1
Doll, R.2
Buckley, J.D.3
-
3
-
-
0028120012
-
The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: Design, methods, participant characteristics, and compliance
-
The ATBC Cancer Prevention Study Group
-
The ATBC Cancer Prevention Study Group. The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994; 4: 1-10.
-
(1994)
Ann Epidemiol
, vol.4
, pp. 1-10
-
-
-
4
-
-
0038116394
-
Incidence of cancer and mortality following α-tocopherol and β-carotene supplementation: A postintervention follow-up
-
The ATBC Study Group
-
The ATBC Study Group. Incidence of cancer and mortality following α-tocopherol and β-carotene supplementation: a postintervention follow-up. JAMA 2003; 290: 476-85.
-
(2003)
JAMA
, vol.290
, pp. 476-485
-
-
-
5
-
-
0036352741
-
The Finnish Cancer Registry as follow-up source of a large trial cohort
-
Korhonen P, Malila N, Pukkala E, et al. The Finnish Cancer Registry as follow-up source of a large trial cohort. Acta Oncol 2002; 41: 381-8.
-
(2002)
Acta Oncol
, vol.41
, pp. 381-388
-
-
Korhonen, P.1
Malila, N.2
Pukkala, E.3
-
8
-
-
9244262406
-
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
-
Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-5.
-
(1996)
N Engl J Med
, vol.334
, pp. 1150-1155
-
-
Omenn, G.S.1
Goodman, G.E.2
Thornquist, M.D.3
-
9
-
-
10644263516
-
The Beta-Carotene and Retinol Efficacy Trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping β-carotene and retinol supplements
-
Goodman GE, Thornquist MD, Balmes J, et al. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping β-carotene and retinol supplements. J Natl Cancer Inst 2004; 96: 1743-50.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 1743-1750
-
-
Goodman, G.E.1
Thornquist, M.D.2
Balmes, J.3
-
10
-
-
49449085278
-
Carotenoids and the risk of developing lung cancer: A systematic review
-
Gallicchio L, Boyd K, Matanoski G, et al. Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr 2008; 88: 372-83.
-
(2008)
Am J Clin Nutr
, vol.88
, pp. 372-383
-
-
Gallicchio, L.1
Boyd, K.2
Matanoski, G.3
-
11
-
-
10344238570
-
α-Tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of base-line characteristics and study compliance
-
Albanes D, Heinonen OP, Taylor PR, et al. α-Tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88: 1560-70.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1560-1570
-
-
Albanes, D.1
Heinonen, O.P.2
Taylor, P.R.3
-
12
-
-
0345157579
-
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
-
Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-9.
-
(1996)
N Engl J Med
, vol.334
, pp. 1145-1149
-
-
Hennekens, C.H.1
Buring, J.E.2
Manson, J.E.3
-
13
-
-
0033572468
-
β-Carotene supplementation and incidence of cancer and cardiovascular disease: The Women's Health Study
-
Lee IM, Cook NR, Manson JE, et al. β-Carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 1999; 91: 2102-6.
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 2102-2106
-
-
Lee, I.M.1
Cook, N.R.2
Manson, J.E.3
-
14
-
-
58549094920
-
Vitamins C and e and beta carotene supplementation and cancer risk: A randomized controlled trial
-
Lin J, Cook NR, Albert C, et al. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst 2009; 101: 14-23.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 14-23
-
-
Lin, J.1
Cook, N.R.2
Albert, C.3
-
15
-
-
0029956537
-
β-Carotene and lung cancer promotion in heavy smokers- A plausible relationship?
-
Mayne ST, Handelman GJ, Beecher G,. β-Carotene and lung cancer promotion in heavy smokers- A plausible relationship? J Natl Cancer Inst 1996; 88: 1513-5.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1513-1515
-
-
Mayne, S.T.1
Handelman, G.J.2
Beecher, G.3
-
16
-
-
0346095555
-
From 1989 to 2001: What have we learned about the "biological actions of beta-carotene"?
-
Bendich A,. From 1989 to 2001: what have we learned about the "biological actions of beta-carotene"? J Nutr 2004; 134: 225S-30S.
-
(2004)
J Nutr
, vol.134
-
-
Bendich, A.1
-
17
-
-
0038692733
-
Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial
-
Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996; 88: 1550-9.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1550-1559
-
-
Omenn, G.S.1
Goodman, G.E.2
Thornquist, M.D.3
-
18
-
-
0032973664
-
Alcohol, vitamin A, and β-carotene: Adverse interactions, including hepatotoxicity and carcinogenicity
-
Leo MA, Lieber CS,. Alcohol, vitamin A, and β-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr 1999; 69: 1071-85.
-
(1999)
Am J Clin Nutr
, vol.69
, pp. 1071-1085
-
-
Leo, M.A.1
Lieber, C.S.2
-
19
-
-
0024503033
-
Carotenoids in human blood and tissues
-
Parker RS,. Carotenoids in human blood and tissues. J Nutr 1989; 119: 101-4.
-
(1989)
J Nutr
, vol.119
, pp. 101-104
-
-
Parker, R.S.1
-
20
-
-
0032542759
-
Prostate cancer and supplementation with α-tocopherol and β-carotene: Incidence and mortality in a controlled trial
-
Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998; 90: 440-6.
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 440-446
-
-
Heinonen, O.P.1
Albanes, D.2
Virtamo, J.3
-
21
-
-
77950874457
-
Cancer-preventive activities of tocopherols and tocotrienols
-
Ju J, Picinich SC, Yang Z, et al. Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis 2010; 31: 533-42.
-
(2010)
Carcinogenesis
, vol.31
, pp. 533-542
-
-
Ju, J.1
Picinich, S.C.2
Yang, Z.3
-
22
-
-
0035135583
-
Effects of long-term α-tocopherol supplementation on serum hormones in older men
-
Hartman TJ, Dorgan JF, Woodson K, et al. Effects of long-term α-tocopherol supplementation on serum hormones in older men. Prostate 2001; 46: 33-8.
-
(2001)
Prostate
, vol.46
, pp. 33-38
-
-
Hartman, T.J.1
Dorgan, J.F.2
Woodson, K.3
-
23
-
-
20044383911
-
Effects of long-term vitamin e supplementation on cardiovascular events and cancer: A randomized controlled trial
-
The HOPE and HOPE-TOO Trial Investigators
-
The HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005; 293: 1338-47.
-
(2005)
JAMA
, vol.293
, pp. 1338-1347
-
-
-
24
-
-
58149375890
-
Vitamins e and C in the prevention of prostate and total cancer in men: The Physicians' Health Study II Randomized Controlled Trial
-
Gaziano JM, Glynn RJ, Christen WG, et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II Randomized Controlled Trial. JAMA 2009; 301: 52-62.
-
(2009)
JAMA
, vol.301
, pp. 52-62
-
-
Gaziano, J.M.1
Glynn, R.J.2
Christen, W.G.3
-
25
-
-
58149383852
-
Effect of selenium and vitamin e on risk of prostate cancer and other cancers: The Selenium and Vitamin e Cancer Prevention Trial (SELECT)
-
Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301: 39-51.
-
(2009)
JAMA
, vol.301
, pp. 39-51
-
-
Lippman, S.M.1
Klein, E.A.2
Goodman, P.J.3
-
26
-
-
80053954605
-
Vitamin e and the risk of prostate cancer: The Selenium and Vitamin e Cancer Prevention Trial (SELECT)
-
Klein EA, Thompson IM, Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 306: 1549-56.
-
(2011)
JAMA
, vol.306
, pp. 1549-1556
-
-
Klein, E.A.1
Thompson, Jr.I.M.2
Tangen, C.M.3
-
27
-
-
0032709750
-
Supplemental vitamin e intake and prostate cancer risk in a large cohort of men in the United States
-
Chan JM, Stampfer MJ, Ma J, et al. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev 1999; 8: 893-9.
-
(1999)
Cancer Epidemiol Biomarkers Prev
, vol.8
, pp. 893-899
-
-
Chan, J.M.1
Stampfer, M.J.2
Ma, J.3
-
28
-
-
33144487901
-
On behalf of the PLCO Trial. Supplemental and dietary vitamin E, β-carotene, and vitamin C intakes and prostate cancer risk
-
Kirsh VA, Hayes RB, Mayne ST, et al, on behalf of the PLCO Trial. Supplemental and dietary vitamin E, β-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 2006; 98: 245-54.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 245-254
-
-
Kirsh, V.A.1
Hayes, R.B.2
Mayne, S.T.3
-
30
-
-
84863613112
-
Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: A nested case-control study
-
Weinstein SJ, Peters U, Ahn J, et al. Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study. PLoS ONE 2012; 7: e40204.
-
(2012)
PLoS ONE
, vol.7
-
-
Weinstein, S.J.1
Peters, U.2
Ahn, J.3
-
31
-
-
0033559952
-
Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis
-
Gann PH, Ma J, Giovannucci E, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999; 59: 1225-30.
-
(1999)
Cancer Res
, vol.59
, pp. 1225-1230
-
-
Gann, P.H.1
Ma, J.2
Giovannucci, E.3
-
32
-
-
34548707081
-
Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition Study
-
Key TJ, Appleby PN, Allen NE, et al. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition Study. Am J Clin Nutr 2007; 86: 672-81.
-
(2007)
Am J Clin Nutr
, vol.86
, pp. 672-681
-
-
Key, T.J.1
Appleby, P.N.2
Allen, N.E.3
-
33
-
-
68449103061
-
Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F2t in serum or urine with prostate cancer risk: The Multiethnic Cohort
-
Gill JK, Franke AA, Morris JS, et al. Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F2t in serum or urine with prostate cancer risk: the Multiethnic Cohort. Cancer Causes Control 2009; 20: 1161-71.
-
(2009)
Cancer Causes Control
, vol.20
, pp. 1161-1171
-
-
Gill, J.K.1
Franke, A.A.2
Morris, J.S.3
|